Current updates on generations, approvals, and clinical trials of CAR T-cell therapy

• Hoofdauteurs: Tadesse Asmamaw Dejenie (Auteur), Markeshaw Tiruneh G/Medhin (Auteur), Gashaw Dessie Terefe (Auteur), Fitalew Tadele Admasu (Auteur), Wondwossen Wale Tesega (Auteur), Endeshaw Chekol Abebe (Auteur)
• Formaat: Boek
• Gepubliceerd in: Taylor & Francis Group, 2022-11-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Chimeric antigen receptor (CAR) T-cell therapy is a novel, customized immunotherapy that is considered a 'living' and self-replicating drug to treat cancer, sometimes resulting in a complete cure. CAR T-cells are manufactured through genetic engineering of T-cells by equipping them with CA...